| Fiscal Year End | Company Status | Exempt Flag |
| October 31 | Delist | N |
|
|
|
|
|
| Incorporation Locations |
| Inc. Date | Expiry Date | Country | Region | Description |
| 19/Aug/1998 | 1/Jun/2022 | Canada | British Columbia | |
|
|
| Exchange Filing Office |
| Location |
| (not available) |
|
|  |
| Business Type(s) |
| Primary/Secondary | Business Type | Details |
| Primary
| *Research And Development In The Life Sciences
| News Release June 3, 2014 -Sernova Corp is a clinical stage regenerative medicine company developing medical technologies for the treatment of chronic debilitating metabolic diseases such as diabetes, blood disorders including haemophilia and other diseases treated through replacement of proteins or hormones missing or in short supply within the body. Sernova is developing the Cell Pouch?, an implantable medical device for therapeutic cells (donor, xenogeneic or stem cells) which then release proteins and/or hormones as required. The therapeutic cells are protected from immune attack by Sernova's proprietary technologies.
|
|
|
| Securities |
| Symbol | Security Name | Market | Status |
| *SVA | *Sernova Corp. | TSX Venture | DELIST |
| *PHS | *Pheromone Sciences Corp. | TSX Venture | DELIST |
| *PHS.RT | *Pheromone Sciences Corp rt 12De03 | TSX Venture | DELIST |
| *MEC | *Mecca Medi-Tech Inc. | TSX Venture | DELIST |
| *MEC | *Mecca Medi-Tech Inc. | VSE | DELIST |
|
|
| Name History | From | To |
| *Sernova Corp. | 20/Sep/2006 | 1/Jun/2022 |
| *Pheromone Sciences Corp. | 2/Mar/2000 | 19/Sep/2006 |
| *Mecca Medi-Tech Inc. | 22/Dec/1998 | 1/Mar/2000 |
|
|
| Company Facts Reconciliation |
| Subject | Date Returned |
| Spring 2015 CFR | Not Received |
|
|
|
|
|
